Peer Review History

Original SubmissionFebruary 6, 2024

Attachments
Attachment
Submitted filename: Response to Reviewers Letter.docx
Decision Letter - Md Nazmul Huda, Editor

PONE-D-24-04972Exploring the perceptions of the effect of the COVID-19 pandemic on the mental well-being of medical students in Northern Ireland; A Qualitative StudyPLOS ONE

Dear Dr. Whiteside,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 16 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Md Nazmul Huda, PhD, MSS, BSS

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that your Data Availability Statement is currently as follows: All relevant data are within the manuscript and its Supporting Information files.

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

3. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

Additional Editor Comments:

In addition to reviewers' comments, please address my below comments:

1) Please indicate the study design in the abstract. Did you follow a descriptive design? Or any other study design? Indicate the analysis technique in the abstract.

2. In the abstract, results lack substances. For example, you talked about impact without indicating the impacts of covid. Please provide more details of impact for the readers.

3. Reduce the number of objectives and mention the objective you addressed and indicated in the paper title/abstract. Or change the title. This means there should be consistency between your paper aim, title and results you described. The current title only indicates the impact. But you described barriers etc. Make necessary changes everywhere.

4. Analysis technique is absent. Please detail.

5. Please summarise your findings in the discussion section before comparing them with other studies.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a qualitative study article on the effect of COVID-19 on the mental well-being of medical students in Northern Ireland. The discussion on the basics is fine and based on a broad understanding of the field. However, it seems to need to with a few sentences in the introduction by focusing more on Northern Ireland during the COVID-19 time to distinguish it from other similar studies (Prevalence rate, government services, accessibility to vaccine...). Also, let me know why the authors decided to interview participants three years after COVID-19. How are authors sure in these years participants were not involved with other emotional damage?

Reviewer #2: Thank you for the paper

- Abstract needs revision. I do not know how the authors mentioned significant results in qualitative. This section needs revision - Methods part needs comprehensive revision

- Add rigor in Method

- In results, show themes, subthemes and code

- Add demographic chchs of the study sample

- Revise discussion and link to results

Reviewer #3: 1. I think, your paper is well written but it is more suitable for PLOS Mental Health Journal.

2. Line number 135: "The principal researcher/author is a female Northern Irish medical student studying..."

why is it necessary to mention the gender of the principal researcher/author?

3. Line number 151: "... average length being 30.4 minutes."

I think Standard deviation should be included here in order to understand the dispersion/spread of the interview length.

4. Line number 593: "This was the first research carried out in NI assessing barriers mental health support utilisation amongst...."

If you are 100% sure about what has been written, then it is alright... Congratulation on your work. But if not, please write as follows: "as far as we know" or "to our knowledge". In that case, it would not create any possible conflict of interest in future.

5. Is NHS under the jurisdiction of Northern Ireland? or it is HSC that is under the jurisdiction of NI? I am pointing out it as the UK NHS has been mentioned in Line number 105. NI may have different publicly governed/funded healthcare system if I am not wrong.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Abd Alhadi Hasan

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Responses to comments made by the academic editor:

I have checked the PLOS style requirements and ensured the manuscript; including tables, figures and references meet the required styles.

This is a qualitative research study. Therefore, all data is in the form of recordings which contain identifiable and sensitive information. Apart from length of participant interviews which is included in the revised manuscript, there is no numerical data or graphs. There are anonymous quotations within the manuscript results section. Upon participant recruitment, the following information was in the participant information letter:

‘The data will be stored anonymously and be inaccessible to all excluding the principal researcher and supervising researcher. The data will be used to write up a thesis project which will be submitted to journals to be potentially published. If the opportunity arises, the results of the research will be made into a poster or PowerPoint for presentation for the potential to be presented at Maastricht University and or a national/international conference. If desired, the thesis will be made accessible to participants after completion. participants were informed all data’.

Upon applying for ethical approval from the Maastricht University Ethics committee, the following information was in the approval request letter:

‘Identifiable data, such as audio recordings and transcripts will only be accessible by the principal researcher. Anonymous data will only be accessible by the research team; made up of the principal researcher and two research supervisors. The principal researcher will act as the data controller.’

‘Other individuals will not be able to access the data as it will be sorted on a password protected file on a password protected laptop during the project. After the project it will be stored on the UM server in password protected files. The data will not be printed.’

‘The data will not be shared or used in future research. However, the thesis has the potential to be published in a journal. Therefore, the publication could potentially be reviewed in a literature review. Potential publication will be referenced in the information and consent form.’

Therefore, sharing the data would both violate the agreement with the participants prior to data collection, in addition to the agreement made upon approval for the research with the Maastricht University ethics committee. The data is currently being securely stored in encrypted files by the principal researcher. Anonymous transcripts can be obtained from the principal researcher, Claire Whiteside on request but they cannot be shared publicly. The University of Maastricht Ethics committee address is Universiteitssingel 40, 6229 ER Maastricht, Netherlands and contact email is ethical_clearance_gh@maastrichtuniversity.nl

The methods section in the abstract has been extended to include additional study design information and analysis technique.

The results section of the abstract has been extended to include additional information.

The title has been changed to more appropriately encompass the four study objectives. There is now consistency throughout the manuscript.

Section 3; methods has been expanded to include more information regarding study design, participant demographics and data analysis technique.

An additional paragraph has been added in section 5 to summarise the research findings prior to comparing the results with other studies.

Responses to comments made by reviewers:

Reviewer 1:

Section 1; the introduction has been adjusted to include more information relevant to COVID-19 in Northern Ireland, such as prevalence, death rates and vaccine uptake.

The participants were interviewed in June 2023. The COVID-19 pandemic initiated in Northern Ireland in March 2020 and all restrictions has ceased 2 years later in March 2022. Therefore, there was a 15-month gap between complete cessation of the pandemic in NI and interviewing participants. The principal researcher decided to complete the research at this point because this is when they were completing a masters in Global Health at Maastricht University. The research was carried out for the purpose of their master’s thesis. The principal researcher felt this was an appropriate time to complete this retrospective qualitative research as participants would be able to recall the effects of the pandemic on their mental health during the pandemic, as well as perceived secondary effects on their medical education; both during the pandemic and at the time of data collection.

Reviewer 2:

The abstract has been revised, with the word ‘significant’ removed and more detail in method section. The results section has been changed, with added adjusted theoretical frameworks (figure 1 and 2) to demonstrate themes, sub-themes and code. Table 1 has been added to demonstrate the demographics of the study sample. The discussion has been revised with added summary paragraph.

Reviewer 3:

I will consider applying to the PLOS mental health journal if the manuscript is not successful in PLOS One.

The gender of the principal researcher has been removed from "The principal researcher/author is a female Northern Irish medical student studying..."

Standard deviation of length of interviews has been added and interview lengths are demonstrated in table 1.

Necessary adjustments have been made to the text to reduce opportunity for possible future conflicts of interest.

The NHS is the National Health service of the UK; including Northern Ireland. There are different branches of the UK health system. NHS England is centrally funded from the Department of Health and Social care while Northern Ireland receives a grant from the UK treasury which funds the Department of health, social services and public safety for Northern Ireland (DHSSPS). The slight difference between health systems in England and NI is that both the health and social care are provided through an integrated service. Therefore, Health and social care Northern Ireland (HSCNI) is part of the overall UK NHS. The sentence (now line 155) has been adjusted to more appropriately reflect this.

Attachments
Attachment
Submitted filename: Response to reviewers letter.docx
Decision Letter - Md Nazmul Huda, Editor

Exploring the perceptions of the effect of the COVID-19 pandemic on the mental well-being and medical education of medical students in Northern Ireland, in addition to the perceived barriers to seeking support; A Qualitative study

PONE-D-24-04972R1

Dear Dr. Claire Whiteside,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Md Nazmul Huda, PhD, MRes, BSS

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Md Nazmul Huda, Editor

PONE-D-24-04972R1

PLOS ONE

Dear Dr. Whiteside,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Md Nazmul Huda

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .